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Abstract Escherichia coli is one of the most widely used
vehicles to overexpress membrane proteins (MPs). Currently, it
is not possible to predict if an overexpressed MP will end up in
the cytoplasmic membrane or in inclusion bodies. Overexpression
of MPs in the cytoplasmic membrane is strongly favoured to
overexpression in inclusion bodies, since it is relatively easy to
isolate MPs from membranes and usually impossible to isolate
them from inclusion bodies. Here we show that green fluorescent
protein (GFP), when fused to an overexpressed MP, can be used
as an indicator to monitor membrane insertion versus inclusion
body formation of overexpressed MPs in E. coli. Furthermore,
we show that an overexpressed MP can be recovered from a
MP^GFP fusion using a site specific protease. This makes GFP
an excellent tool for large-scale MP target selection in structural
genomics projects. ß 2001 Federation of European Biochemi-
cal Societies. Published by Elsevier Science B.V. All rights
reserved.
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1. Introduction
With integral membrane proteins (MPs) accounting for 20^
25% of all open reading frames in fully sequenced genomes,
and their well-recognised importance as e.g. drug targets, they
represent one of the most challenging classes of proteins in the
areas of overexpression/puri¢cation and structural biochemis-
try [1,2]. The overexpression problems associated with MPs
are a major bottleneck to overcome in studies of MP structure
and function. Escherichia coli is one of the most widely used
vehicles in attempting to overexpress both pro- and eukaryotic
MPs. Overexpression of MPs in the cytoplasmic membrane is
strongly favoured to overexpression in inclusion bodies, since
it is relatively easy to isolate MPs from membranes, and usu-
ally impossible to isolate them from inclusion bodies. Un-
fortunately, it is not possible to predict whether an overex-
pressed MP will end up in the cytoplasmic membrane or in
inclusion bodies.
Ideally, one would like to screen the expression of large
numbers of MPs, but this is very time consuming using stan-
dard technology. For this reason we set out to develop an MP
overexpression screen in E. coli using green £uorescent protein
(GFP) as a folding indicator to distinguish between cytoplas-
mic membrane insertion versus inclusion body formation.
GFP was chosen as it has been shown to be a sensitive folding
indicator for the overexpression of globular proteins [3]. In
short : when GFP is fused to the C-terminus of overexpressed
globular proteins, then overexpression in a soluble form al-
lows GFP to fold correctly and become £uorescent. However,
if the globular protein-GFP fusion is overexpressed in inclu-
sion bodies then GFP is not £uorescent.
In this report, we show that the use of GFP as a folding
indicator can be expanded to encompass MP overexpression
in E. coli ; i.e. GFP can be used to distinguish between the
overexpression of MPs in the cytoplasmic membrane and in
inclusion bodies. Furthermore, we show that an overexpressed
MP can be recovered from an MP^GFP fusion using a site
speci¢c protease. This makes GFP an excellent tool for large-
scale MP target selection in structural genomics projects.
2. Materials and methods
2.1. Cloning and culture conditions
The genes coding for the E. coli MPs YidC [4], ProW [5], Lep-inv
[6], the E. coli M13 bacteriophage MP procoat protein [7], the rat MP
olfactory GPCR OR5 with an N-terminally fused glutathione-S-trans-
ferase (GST)-tag [8] and the human MP KDEL-receptor [9] were
ampli¢ed by conventional PCR from plasmids available in house,
and cloned into the C-terminal GFP fusion expression vector con-
structed by Waldo et al. [3]. This vector is a modi¢ed pET28(a+)
vector, and it contains a GFP variant that is selected to fold well in
E. coli and has the red-shifted mutation S65T and the folding muta-
tion F64L [10]. The expression vectors harbouring the MP^GFP fu-
sions were transformed freshly for each experiment into BL21(DE3)-
pLysS and grown in 50 ml cultures on Luria broth (LB) medium
containing 50 Wg/ml kanamycin and 30 Wg/ml chloroamphenicol. Cells
were initially cultured at 37‡C. When the cultures had reached an
OD600 of 0.3^0.4, the temperature was switched to 25‡C and MP^
GFP fusion expression was induced for 10 h with 0.4 mM isopropyl-
L-D-thiogalactoside (IPTG).
2.2. Cell fractionation
After expression, cells were harvested and re-suspended in 1 ml of
bu¡er containing 50 mM Tris^HCl pH 8.0, 200 mM NaCl, 15 mM
EDTA and 100 WM PMSF (hereafter referred to as sonication bu¡er).
Cells were sonicated on ice using a Xl-gies Microson (Heat Systems
Incorporated) sonicator. Cells were sonicated at 50% duty cycle for
four 45 s bursts with 1 min intervals. The sonication mixture was
subsequently centrifuged for 10 min at 13 000 rpm in a microfuge to
isolate any inclusion bodies and unbroken cells (hereafter referred to
as the low speed spin pellet fraction). The supernatant of the low
speed spin was centrifuged in a Beckman TL-100 table ultracentrifuge
in a TLA100.2 rotor for 1 h at 80 000 rpm to isolate the cytoplasmic
membranes (hereafter referred to as the high speed spin pellet frac-
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tion) and the soluble fraction (hereafter referred to as the high speed
spin supernatant fraction).
2.3. Fluorescence measurements
The low speed spin and the high speed spin pellet fractions were re-
suspended in 1 ml of sonication bu¡er. For whole cell £uorescence
measurements, 1 ml of culture was taken from the 50 ml cell cultures
before sonication. Cells were harvested and subsequently re-suspended
in 1 ml of sonication bu¡er minus PMSF. GFP emission of all these
samples and the high speed spin supernatant fraction was measured
using a Perkin-Elmer LS50B spectro£uorimeter with the excitation
wavelength set at 480 nm and the emission wavelength set at 508
nm (the bandwidth for each was set at 5 nm), essentially as described
by Waldo et al. [3]. For comparison, all the GFP £uorescence data
were normalised by the maximum £uorescence signal.
2.4. Immunoblotting
5% of the low/high speed spin pellet fractions, and 1 ml whole-cell
suspension, that had previously been used for £uorescence measure-
ments, were re-centrifuged and re-suspended in 20 Wl of sodium do-
decyl sulphate^polyacrylamide gel electrophoresis (SDS^PAGE) solu-
bilisation (SB) bu¡er. The high speed spin supernatant was adjusted
to the same v/v with SB bu¡er. 17.5 Wl of the high speed spin super-
natant and 10 Wl of the other samples was used for separation in
standard 12% SDS^polyacrylamide gels. Proteins were subsequently
transferred from the gel to a PVDF membrane by means of Western
blotting. Blots were decorated with either speci¢c antibodies to the
di¡erent MPs used in this study (in house antibody collection) or with
a GFP speci¢c antibody (Novagen). Blots were developed using the
alkaline phosphatase system (according to the instructions of the
manufacturer, Sigma).
Blots of the cell fractionation experiments were scanned using a
standard £atbed scanner (MICROTEK ScanMakerX12USI), and in-
dividual band densities were measured and compared using the NIH
imaging software (http://rsb.info.nih.gov/nih-image/) to a known
amount of YidC-GFP standard to calculate the expected £uorescence
for all MP^GFP fusions.
2.5. Construction, puri¢cation and proteolytic cleavage of
YidC-TEV-GFP-His
Using linker insertion the DNA sequence encoding the amino acid
sequence for the recombinant tobacco etch virus (TEV) protease
cleavage site (protease recognition site: ENLYFQ/G;/: cleavage site)
was introduced between the polylinker and the gene encoding GFP in
Waldo’s expression vector (see Section 2.1) [11]. Subsequently, the C-
terminal stop codon in GFP in Waldo’s expression vector was re-
moved by site directed mutagenesis to include transcription of six
histidines, yielding the expression vector pWaldo-TEV-GFP-His.
The gene encoding YidC was subcloned into pWaldo-TEV-GFP-
His. YidC-TEV-GFP-His was expressed in 1 l cultures, essentially
as described in Section 2.1. Cells were spun down and re-suspended
in 5 ml of sonication bu¡er. Subsequently, 50 mg of lysozyme, 10 mM
MgCl2 and some grains of DNAseI were added. Cells were lysed by
repeated freeze thawing, followed by sonication. Membranes were
isolated as described in Section 2.2. Membranes were washed in 1 ml
of EDTA-free sonication bu¡er, re-centrifuged at 13 000 rpm for
20 min, and solubilised in 1 ml of 2% (w/v) n-dodecyl-L-D-maltoside
(DDM), 10 mM Tris^HCl pH 8.0, 100 mM NaCl, 10 mM imidazole,
and 20% (v/v) glycerol. The YidC-TEV-GFP-His fusion was puri¢ed
essentially as described by van der Laan et al. [12].
The puri¢ed YidC-TEV-GFP-His fusion was incubated overnight
at 30‡C in the presence and absence of the recombinant TEV pro-
tease, as described in the manufacturer’s instructions (Invitrogen).
Fractions of the incubations were dissolved in SB bu¡er, and sepa-
rated in 12% SDS^polyacrylamide gels. Proteins were subsequently
transferred from the gel to a PVDF membrane by means of Western
blotting. Blots were decorated with either an antibody to YidC or an
antibody to GFP. Blots were developed as described in Section 2.4.
3. Results
3.1. MP^GFP fusions
A set of well-characterised pro- and eukaryotic MPs was
Fig. 1. Schematic representation of the MP^GFP fusions. A: MPs that express in E. coli predominantly in the cytoplasmic membrane. ProW,
an E. coli MP that is part of the ProU osmoregulatory system [5]; YidC, an E. coli MP that is involved in MP assembly [4]; Lep-inv, a deriva-
tive of the E. coli MP leader peptidase that inserts with an inverted topology [6]; KDEL-receptor, human ERD2 receptor that is involved in
the tra⁄cking of proteins from the Golgi complex to the endoplasmic reticulum (ER) [17]. B: MPs that express in E. coli predominantly in in-
clusion bodies. M13 procoat, a bacteriophage coat protein [7]; GST-GPCR, a rat olfactory receptor with an N-terminal GST-tag [8].
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used to study the use of GFP as an MP folding indicator in E.
coli (Fig. 1). All selected MPs were known to express well in
E. coli, either predominantly in the cytoplasmic membrane
(ProW, YidC, Lep-inv, KDEL-receptor), or predominantly
in inclusion bodies (GST-GPCR, M13 procoat). As GFP is
incorrectly folded as a C-terminal fusion that is translocated
into the periplasm [13], we only selected MPs that have their
C-termini located in the cytoplasm. Since at least 70% of all
MPs are predicted to have this topology [14], the majority of
MPs could be tested for overexpression in E. coli using this
approach.
3.2. MP^GFP fusion expression analysis
All selected MPs were cloned into the C-terminal GFP fu-
sion expression vector that has been constructed by Waldo et
al. [3]. MP^GFP fusions were overexpressed in E. coli strain
BL21(DE3)pLysS. After induction, expression of the MP^
GFP fusions were detectable in whole cells by means of im-
munoblotting with MP speci¢c antibodies (results not shown)
and with a GFP antibody (Fig. 2A).
To monitor the expression status of the MP^GFP fusions
(i.e. expression in the cytoplasmic membrane versus expres-
sion in inclusion bodies), MP^GFP fusion overexpressing cells
were subfractionated. Cells were broken by means of sonica-
tion. The sonicated cells were subsequently subjected to a low
speed centrifugation spin to collect unbroken cells/inclusion
bodies (hereafter referred to as the low speed spin pellet).
The supernatant of the low speed centrifugation spin was
subsequently subjected to a high speed centrifugation spin
to isolate the cytoplasmic membranes and the soluble fraction
(hereafter referred to as the high speed spin pellet fraction and
high speed spin supernatant fraction, respectively). The di¡er-
ent subfractions were analysed by means of immunoblotting
with a GFP antibody. An example of a subfractionation ex-
periment, where most of MP^GFP (human KDEL-GFP) fu-
sion appears to be in the cytoplasmic membrane is shown in
Fig. 2B, and an example where most of MP^GFP (rat olfac-
tory GST-GPCR-GFP) fusion appears to be in inclusion
bodies is shown in Fig. 2C.
3.3. Comparing GFP emission from whole cells to isolated
membranes
Breakage of E. coli cells by sonication is never complete (see
e.g. [15]). This made it necessary to study if the GFP emission
from the low speed spin pellet fraction was produced by un-
broken cells rather than £uorescent inclusion bodies. Using a
GFP antibody we quanti¢ed on Western blots the band in-
tensity of the MP^GFP fusions present in equivalent amounts
of the low speed spin pellet fraction and the high speed spin
pellet fractions. Subsequently, the GFP emission from these
fractions was estimated and plotted against the GFP emission
measured (Fig. 3A and B). It was clear that for the MPs
which are known to be expressed predominantly in inclusion
bodies (M13 procoat protein, GST-GPCR), expected GFP
emission present in the low speed spin pellet fraction did
not correlate to the GFP emission measured. We estimated
that 53% of M13-GFP and 86% of GST-GPCR-GFP fusion
proteins formed inclusion bodies that did not contribute to
any GFP emission. These inclusion bodies were isolated using
a sucrose step gradient [16], and no GFP emission could be
detected (results not shown).
Contrary, the GFP emission present in the low speed spin
pellet fraction from MPs expected to be expressed predomi-
nantly in the cytoplasmic membrane (YidC, ProW, Lep-inv,
KDEL-receptor), corresponded very nicely to observed GFP
emission, indicating the presence of mostly unbroken cells
rather than inclusion bodies in the low speed spin pellet frac-
tion.
In the high speed spin pellet fractions, all MP^GFP fusions
produced an estimated GFP emission that correlated well to
the GFP emission measured. This indicated no bias when
using GFP emission from isolated membranes to estimate ex-
pression levels. To re-con¢rm the amount of non-£uorescent
inclusion bodies, the low speed spin fraction was adjusted to
reach the same GFP emission levels measured in the high
speed spin fraction and analysed by means of Western blot-
ting using a GFP antibody (Fig. 3C).
In our set of MP^GFP fusions the amount of GFP emis-
sion measurable from isolated membranes compared well to
the amount of MP expression in the cytoplasmic membrane.
Because the GFP emission measurable in the low speed spin
pellet fraction was produced by unbroken cells only, whole
cell GFP emission was used to estimate MP expression levels
in the cytoplasmic membrane (Fig. 3D).
3.4. MP recovery from an overexpressed MP^GFP fusion
We have explored the possibility to recover MPs from MP^
GFP fusions using YidC-GFP as an example. In this respect it
is worth mentioning that, so far, we have not observed any
notable di¡erences between the overexpression of MPs fused
and not fused to GFP (our unpublished observations). To
facilitate the puri¢cation of YidC-GFP, a 6His-tag was engi-
Fig. 2. MP^GFP expression. A: Western blots on whole cells after
MP^GFP fusion overexpression. Gels were run and blots were de-
veloped using a GFP antibody as described in Section 2. Lane 1,
KDEL-GFP; lane 2, GST-GPCR-GFP; lane 3, YidC-GFP; lane 4,
Lep-inv-GFP; lane 5, ProW-GFP; and lane 6, M13-GFP. B: West-
ern blots on subfractions of E. coli KDEL-GFP overexpressing
cells. Gels were run and blots were developed using a GFP antibody
as described in Section 2. Lane 1, low speed spin pellet fraction;
lane 2, high speed spin pellet fraction; and lane 3, high speed spin
supernatant fraction. C: Western blots on subfractions of E. coli
GST-GPCR-GFP overexpressing cells. Gels were run and blots were
developed using a GFP antibody as described in Section 2. Lane 1,
low speed spin pellet fraction; lane 2, high speed spin pellet frac-
tion; and lane 3, high speed spin supernatant fraction.
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neered to the C-terminus of the fusion. To separate YidC and
GFP, the site speci¢c TEV protease cleavage site was intro-
duced between YidC and GFP. The resultant YidC-TEV-
GFP-His fusion could be puri¢ed using Ni2-NTA chroma-
tography under similar conditions to YidC-His (Fig. 4A) [12].
Subsequently, at 50 mM imidazole puri¢ed YidC-TEV-GFP-
His was incubated with the TEV protease, and protease di-
gests were analysed by means of immunoblotting with anti-
bodies to YidC and GFP (Fig. 4B). Strikingly, separation of
YidC from the GFP moiety was almost complete.
Fig. 3. GFP as an indicator to monitor MP overexpression. A: Comparison of the GFP emission estimated from the low speed spin pellet frac-
tion by means of Western blotting using a GFP antibody to GFP emission measured by £uorescence spectro£uorimetry as described in Section
2. B: Comparison of the GFP emission estimated from the high speed spin pellet fraction by means of Western blotting using a GFP antibody
to GFP emission measured by £uorescence spectro£uorimetry as described in Section 2. C: Western blots of MP^GFP low speed spin pellet
(L) and high speed spin pellet (H), adjusted to the same GFP emission levels. Gels were run and blots were developed using a GFP antibody
as described in Section 2. D: Estimated MP^GFP expression levels from whole cell GFP emission. As a standard puri¢ed GFP was used.
Fig. 4. MP recovery from an overexpressed MP^GFP fusion. A: Puri¢cation of YidC-TEV-GFP-His. Coomassie staining of SDS^PAGE gel
representing puri¢cation of YidC-TEV-GFP-His by Ni2-NTA chromatography. Lane 1, solubilised inner membrane vesicles; lane 2, unbound
material; lane 3, elution fraction in 30 mM imidazole; lane 4, elution fraction in 50 mM imidazole; and lane 5, elution fraction in 150 mM
imidazole. B: Analysis of TEV protease digests. Western blots were decorated with antibodies to either YidC or GFP. Lane 1, YidC-TEV-
GFP-His without TEV protease (control); lane 2, YidC-TEV-GFP-His with TEV protease; and lane 3, YidC-TEV-GFP-His with an excess of
TEV protease.
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4. Discussion
E. coli is one of the most widely used vehicles to overex-
press both pro- and eukaryotic MPs. Overexpression of MPs
in the E. coli cytoplasmic membrane is strongly favoured to
overexpression in inclusion bodies, since it is relatively easy to
isolate MPs from membranes, and usually impossible to iso-
late them from inclusion bodies. In this report, we show using
a well-characterised set of MPs that GFP can be used as an
indicator for MP overexpression in E. coli ; i.e. GFP can be
used to distinguish between overexpression of MPs in the
cytoplasmic membrane or in inclusion bodies. With the set
of model MPs used in this study, we show that when the
overexpressed MP^GFP fusion is expressed as inclusion
bodies, GFP is not £uorescent. Contrary, if the MP^GFP is
inserted into the cytoplasmic membrane, GFP can fold prop-
erly and becomes £uorescent. In addition, we show that GFP
is not only an indicator for the overexpression status of MPs,
but can also be used to estimate the overexpression levels of
MPs in the cytoplasmic membrane of whole cells.
Though we have not observed the formation of MP^GFP
inclusion bodies that are £uorescent, it cannot be excluded
that in some rare cases MP^GFP inclusion bodies are £uores-
cent. Another drawback with using GFP as an indicator to
monitor MP overexpression, is that GFP may be clipped o¡
from the MP^GFP fusions by proteases in vivo. In our study,
we have observed only some proteolysis (see Fig. 2B), which is
consistent with marginal or absent GFP emission from the
high speed spin supernatant fraction (data not shown). This
still means that there are potential risks to overestimate the
amount of expression in the cytoplasmic membrane when
GFP emission is measured from whole cells. Fortuitously,
any gross overestimate of MP overexpression in the cytoplas-
mic membrane in whole cells can easily be ¢ltered out by
monitoring the GFP emission in isolated membranes. In con-
clusion, we have shown that GFP is an excellent indicator to
monitor MP overexpression in E. coli. Preliminary results in-
dicate that whole cell MP^GFP expression can easily be moni-
tored on a microtitre plate dish format (our unpublished ob-
servations). This will signi¢cantly help in screening the
expression of a large number of MPs, and to select the MPs
that are overexpressed in the cytoplasmic membrane in su⁄-
ciently high amounts for functional and structural studies.
Furthermore, we have shown that MP^GFP fusions can be
used to recover overexpressed MPs. Therefore, GFP is an
excellent tool for the large-scale MP target selection in struc-
tural genomics projects.
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